Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
public_health_agencies:canada:john_conly [2022/01/09 07:32] liam [W21C] | — (current) | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== John Conly ====== | ||
- | {{ : | ||
- | |||
- | Dr. **John Conly**, MD, CM, CCFP, FRCPC, FCAHS, FAMMI, FACP, FSHEA, FIDSA, is a specialist in infectious diseases in Alberta, Canada. | ||
- | ===== Affiliations ===== | ||
- | |||
- | ==== Alberta Health Services ==== | ||
- | |||
- | Conly is an Infectious Disease / IPC Expert for the [[: | ||
- | |||
- | ==== Alberta Medical Association ==== | ||
- | |||
- | Conly received the Medal for Distinguished Service from the [[:Alberta Medical Association]] for " | ||
- | |||
- | ==== AMR One Health Consortium ==== | ||
- | |||
- | Conly is a Work Package Lead, Principal Investigator, | ||
- | |||
- | ==== Canadian Committee on Antibiotic Resistance ==== | ||
- | |||
- | Conly served as Chairman of the Board for the [[:Canadian Committee on Antibiotic Resistance]] (CCAR). | ||
- | |||
- | ==== Canadian Expert Advisory Group on Antimicrobial Resistance ==== | ||
- | |||
- | Conly is a member of the [[:Canadian Expert Advisory Group on Antimicrobial Resistance]] (CEAGAR). | ||
- | |||
- | ==== Canadian Expert Drug Advisory Committee ==== | ||
- | |||
- | Conly served as Vice Chair of the [[:Canadian Expert Drug Advisory Committee]] (CEDAC). | ||
- | |||
- | ==== Canadian Infectious Disease Society ==== | ||
- | |||
- | Conly formerly served as President of the [[:Canadian Infectious Disease Society]] (CIDS). | ||
- | |||
- | ==== University of Calgary ==== | ||
- | |||
- | Conly is a Professor of Medicine, Microbiology, | ||
- | |||
- | === Snyder Institute for Chronic Diseases === | ||
- | |||
- | Conly is the former Co-Director for the [[:Snyder Institute for Chronic Diseases]] at the University of Calgary. | ||
- | |||
- | ==== W21C ==== | ||
- | |||
- | Conly is the Medical Director of [[:W21C]], a research and innovation initiative based in the [[: | ||
- | |||
- | ==== World Health Organization ==== | ||
- | |||
- | Conly is a member of the [[:World Health Organization]] Advisory Group on Integrated Surveillance of Antimicrobial Resistance. |